Nuveen Asset Management, LLC Arcutis Biotherapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 807,650 shares of ARQT stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

807,650

Previous 735,042 9.88%

Holding current value

$10.2 Million

Previous $6.84 Million 9.89%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.32 - $11.0 $604,098 - $798,688	72,608 Added 9.88%	807,650 $7.51 Million
Q2 2024 Aug 09, 2024	BUY	$7.24 - $12.53 $3.52 Million - $6.1 Million	486,856 Added 196.17%	735,042 $6.84 Million
Q1 2024 May 13, 2024	BUY	$3.25 - $11.77 $111,640 - $404,311	34,351 Added 16.06%	248,186 $2.46 Million
Q4 2023 Feb 14, 2024	SELL	$1.84 - $4.82 $9,829 - $25,748	-5,342 Reduced 2.44%	213,835 $690,000
Q3 2023 Nov 14, 2023	BUY	$5.31 - $10.98 $34,414 - $71,161	6,481 Added 3.05%	219,177 $1.16 Million
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $818,101 - $1.63 Million	108,935 Added 104.99%	212,696 $2.03 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $17.14 $10,485 - $17,568	-1,025 Reduced 0.98%	103,761 $1.14 Million
Q4 2022 Feb 14, 2023	SELL	$13.96 - $20.4 $5.98 Million - $8.73 Million	-428,089 Reduced 80.34%	104,786 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $3.07 Million - $4.63 Million	171,732 Added 47.55%	532,875 $10.2 Million
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $2.36 Million - $3.21 Million	144,763 Added 66.9%	361,143 $7.7 Million
Q1 2022 May 16, 2022	BUY	$14.38 - $22.79 $81,117 - $128,558	5,641 Added 2.68%	216,380 $3.57 Million
Q4 2021 Feb 14, 2022	SELL	$14.98 - $25.5 $129,621 - $220,651	-8,653 Reduced 3.94%	210,739 $4.37 Million
Q3 2021 Nov 12, 2021	SELL	$19.28 - $27.1 $857,073 - $1.2 Million	-44,454 Reduced 16.85%	219,392 $4.97 Million
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $997,263 - $1.42 Million	40,838 Added 18.31%	263,846 $7.2 Million
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $1.04 Million - $1.57 Million	42,366 Added 23.45%	223,008 $6.45 Million
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $2 Million - $3.56 Million	112,262 Added 164.17%	180,642 $5.08 Million
Q3 2020 Nov 16, 2020	BUY	$23.44 - $32.28 $572,522 - $788,439	24,425 Added 55.57%	68,380 $2 Million
Q2 2020 Aug 14, 2020	BUY	$24.48 - $36.56 $123,844 - $184,957	5,059 Added 13.01%	43,955 $1.33 Million
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $719,576 - $1.44 Million	38,896 New	38,896 $1.16 Million

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $763M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Arcutis Biotherapeutics, Inc. Transaction History